Qixin Liu
9 papers in the catalog · Canada
Qixin Liu: 9 papers in the catalog · Canada · Rapid Novor Inc. · Works on EasyM M-protein monitoring, Living proteomics benchmark, M-protein de novo sequencing and tracking
Affiliations
Elsewhere
Papers
- A living proteomics benchmark for comprehensive evaluation of deep learning-based de novo peptide sequencing tools (2026, Nature Methods (Registered Report))
- Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases (2025, Nature Communications)
- Enhancing De Novo Protein Sequencing through the C-Terminal Labeling Strategy: Resolving Isobaric Ambiguities by Electron-Transfer/Higher Energy Collision Dissociation (EThcD) (2024, Analytical Chemistry)
- De novo protein sequencing of antibodies for identification of neutralizing antibodies in human plasma post SARS-CoV-2 vaccination (2024, Nature Communications)
- Ultra-sensitivity metaproteomics redefines the gut “dark metaproteome”, uncovering host-microbiome interactions and drug targets in intestinal inflammatory diseases (2024, bioRxiv)
- de Novo Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination (2024, bioRxiv)
- PaSER Novor: Real-time de novo sequencing for 4D-Proteomics applications (2023)
- A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM) (2021, Clinical Cancer Research)
- Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients (2021, Journal of Proteome Research)
Methods and tools
EasyM M-protein monitoring, Living proteomics benchmark, M-protein de novo sequencing and tracking, PaSER Novor, Polyclonal IgG neutralizing antibody discovery, R-met C-terminal labeling de novo sequencing, uMetaP / novoMP